BUT.....the SEC results were significant if you only looked at those with moderate to severe rotator cuff tendinopathy? Curious study, I think worthy of a well designed prospective trial. https://t.co/kqGink3sjU

• https://twitter.com/doctorRBC/status/1400647228310556672

Baseline Vitamin D 😎☀️correlated with biologic response in RA pts. ⭐️EULAR good response: 19.6% Vit D >20 vs 4.2%⬇️Vit D ⭐️Remission: 14.4% ⬆️Vit D vs 3.2% ⬇️Vit D Abs#POS0100 #EULAR2021 @RheumNow

Time to go raspberry picking? Rubus idaeus leaf extract 400mg and 200mg after 12 weeks ⬇️ VAS pain in knee OA compared to placebo ⭐️no effect on WOMAC, SF-36, 20m walking Abs#POS0281 #EULAR2021 @RheumNow https://t.co/QAiag2XjRh

Fellow rheumatologists, make sure to take care of yourself! Latin America study ⭐️57% rheumatologists experienced burnout ⭐️associated with ⬇️age, ⬆️hours, ⬇️satisfaction, ⬇️happiness, ⬆️suicidal thoughts, income Abs#POS0302 #EULAR2021 @RheumNow

MSK US before 1st clinic visit? Abs#POS0260 showed ⬇️ in time to diagnosis of inflammatory arthritis from 31 to 12 days and ⬇️clinical visits 2.8 to 2.1 How do you use MSK US in your clinic? #EULAR2021 @RheumNow

Mavrilimumab (GM-CSFi) phase II trial of COVID-19 PNA and systemic hyperinflammation ⭐️65% risk reduction in ventilation/death ⭐️no sig difference in ventilation requirement ⭐️no serious AE Abs#LB0001 #EULAR2021 @RheumNow

Excellent talk on SLE, APS abs pregancy ⭐️pregnancy counseling is important ⭐️aspirin 81mg in all pregnant SLE pts ⭐️do not discontinue HCQ ⭐️stable LN - can switch MMF to AZA Abs#6888 #EULAR2021 @RheumNow

Close call between LLDAS and DORIS Remission as a treat-to-target in #SLE. Thank you for participating in the polls #EULAR2021 @RheumNow https://t.co/r3OnSrmQkH

• https://twitter.com/Yuz6Yusof/status/1400091034370166785

Results are out. The majority would use #anifrolumab to treat refractory skin and joints disease #SLE. Thank you for participating in the polls #EULAR2021 @RheumNow https://t.co/wguBCkhZ7B

• https://twitter.com/Yuz6Yusof/status/1400514667018063877

No clear winner here. The majority would use #IL23 inhibitors as either 2nd or 3rd line bDMARDs and for #psoriaticarthritis with severe #psoriasis. Thank you for participating in the polls #EULAR2021 @RheumNow https://t.co/b8wzaRVTqw

• https://twitter.com/Yuz6Yusof/status/1400751549090041857

This is by far the biggest rheum dx COVID vaccinated cohort described I'm aware of 👏 Looking forward to full paper, & we will need data with more pts, more details, cellular response etc. Nevertheless, invaluable & reassuring. So glad to see it at #EULAR2021 LB0003 @RheumNow https://t.co/jsHZjLdCTT

6. Rheum disease activity was stable with COVID vaccination. (RA, PsA, axSpA, SLE - total n = 597) 7/ LB0003 #EULAR2021 @RheumNow https://t.co/xxkrunjPa0

Israel was early to COVID vaccinate on mass scale. How well did the vaccine work in their rheum dx pts? rheum pts n=686 (vs controls n = 121) - fewer w immunogencity, but not bad (86% vs 100%) - safety good - dx activity stable more details below ⬇️ LB0003 #EULAR2021 @RheumNow https://t.co/h2WT404mkF

Rituximab in PMR. Intriguing proof of concept (SB?) RCT (1:1, total n=47 (recent dx 38/relapsing 9)) 17w rapid PNL taper ritux 1g x1 21w: steroid-free remission: 48% v 21% PNL ≤5mg/d: 100% v 54% effect mainly from recent dx pts We do need options! POS0343 #EULAR2021 @RheumNow https://t.co/g6xJekY92O

Treat-to-target is the robust algorithm that dictates all modern RA treatment. What's the target? Ummmm We use it in everyone, right? (both doctors & pts say 66%) We at least use the principles sometimes, right? (86% of us) [holds up mirror to self] POS0305 #EULAR2021 @RheumNow https://t.co/A9MXHMYbag